Just put the patch on your arm,leave it on for 10 seconds,then you get the vaccine.According to the scientists,the patch has 5000 very small needles.They are so small that you won't feel afraid .Now scientists are testing the patch on people .We may use it in two years when it's...
【答案】B 【详解】 句意:由于COVID-19仍在迅速传播,接种疫苗是非常必要的。 考查连词辨析。before 在...以前, 引导时间状语从句;since 由于,引导原因状语从句; although 尽管,引导让步状语从句;unless 除非,引导条件状语从句。分析语境可知,前半 句是一个原因状语从句,空处表示“由于” 。 故选B。 反馈 收藏...
解析 B 句意:由于新型冠状病毒仍在快速传播,接种疫苗是非常必要的。before在……之前;since由于;although尽管;unless除非。根据“ the COVID-19 is still spreading rapidly, getting a vaccine(疫苗) is quite necessary”可知,“新型冠状病毒仍在快速传播”是接种疫苗的原因,用since引导原因状语从句,故选B。
Even so, experts say the problemswith undercounts are outweighed by the benefit of home tests. They’re more convenient, meaning people are more likely to get tested. “The most important thing is that people have easy access to testing and can get those tests done,” he said. People are...
——每个人都应该接种疫苗,否则我们将面临更大的危险。 考查形容词及比较级辨析。biggest最大的;bigger更大的;smaller更小的;smallest最小的。根据题干“Everyone should take a vaccine, or we will be in even…danger”,可知不接种疫苗将面临更大的危险,even修饰比较级,故选B。
【题目】I'm getting a COVID-19 vaccine (接种新冠疫苗) this aftermoon.Everyone should take a vaccine, or we will be in evendanger.A.biggestB.biggerC. smallerD. smallest 相关知识点: 试题来源: 解析 【解析】【答案】5【解析】【详解】句意:—我今天下午要去接种新冠疫苗,—每个人都应该接种...
[解答]As soon as一...就...;Since自从、由于;So that以便,getting a vaccine(疫苗) is quite necessary."...COVID﹣19仍在迅速传播。"可知,用Since引导原因状语从句。 故选:B。 [分析]由于COVID﹣19仍在迅速传播,所以接种疫苗是非常必要的。反馈 收藏 ...
根据名词 vaccine 可知此处表示特指,因此要用定冠词 the。故填 The。steadily 解析:考查副词。句意:中国生物科技集团将按照研究计划,稳步开展国际三期临床试验,继续开展中国与其他国家在疫苗研发方面的学术交流,这是疫苗研制中常见的做法。根据谓语动词 make efforts in 可知此处要用副词。故填 steadily。which 解析:...
Coronavirus Antibody Testing What Is a COVID-19 Antibody Test? An antibody test is a screening for things called antibodies in your blood. Your body makes these when it fights an infection, such as COVID-19. The same thing happens when you get a vaccine, such as a flu shot. That’s ...
BEIJING, May 5 (Xinhua) -- A China-developed recombinant protein vaccine against COVID-19 has shown to be safe and effective in the late-stage human trials, according to a study published online in The New England Journal of Medicine on Thursday. ...